Cindy Jacobs
2020
In 2020, Cindy Jacobs earned a total compensation of $773.9K as President and Chief Medical Officer at OncoGenex Pharmaceuticals, a 33% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $159,580 |
|---|---|
| Option Awards | $194,091 |
| Salary | $420,231 |
| Total | $773,902 |
Jacobs received $420.2K in salary, accounting for 54% of the total pay in 2020.
Jacobs also received $159.6K in non-equity incentive plan and $194.1K in option awards.
Rankings
In 2020, Cindy Jacobs' compensation ranked 9,621st out of 13,090 executives tracked by ExecPay. In other words, Jacobs earned more than 26.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,621 out of 13,090 | 27th |
Division Manufacturing | 4,131 out of 5,621 | 27th |
Major group Chemicals And Allied Products | 1,688 out of 2,254 | 25th |
Industry group Drugs | 1,480 out of 1,954 | 24th |
Industry In Vitro and In Vivo Diagnostic Substances | 42 out of 60 | 30th |
Source: SEC filing on March 30, 2021.
Jacobs' colleagues
We found two more compensation records of executives who worked with Cindy Jacobs at OncoGenex Pharmaceuticals in 2020.
News
OncoGenex Pharmaceuticals CEO John Bencich's 2022 pay slips 7% to $1.5M
April 28, 2023
OncoGenex Pharmaceuticals CEO John Bencich's 2021 pay jumps 82% to $1.6M
April 21, 2022
OncoGenex Pharmaceuticals CEO Richard Stewart's 2020 pay jumps 30% to $1M
March 30, 2021
OncoGenex Pharmaceuticals CEO Richard Stewart's 2019 pay falls 27% to $797K
April 2, 2020
OncoGenex Pharmaceuticals CEO Richard Stewart's 2018 pay jumps 423% to $1.1M
March 28, 2019